Cobepa, a private equity firm, completed an investment in Reaction Biology, a provider of drug discovery services. Financial terms were not disclosed. "With John's deep experience growing life sciences companies, we believe this partnership will bring significant benefit to Reaction's customers, employees, and investors alike," Peter Connolly, Cobepa Managing Director.